Difference between revisions of "UPICT TEST SITE - Modified"
Line 7: | Line 7: | ||
1. Executive Summary, Introduction and Background Information | 1. Executive Summary, Introduction and Background Information | ||
− | + | :1.1. Principle | |
− | + | :1.2. Indications | |
− | + | :1.3. Relationship with other diagnostic methods | |
− | + | :1.4. Covariates (note – please see full FDG-PET document; should this material be in other sections of the document?) | |
2. Claims (what users will be able to achieve) | 2. Claims (what users will be able to achieve) | ||
:2.1 Claim #1: | :2.1 Claim #1: | ||
Line 18: | Line 18: | ||
:2.5. Claim #5: (etc.) | :2.5. Claim #5: (etc.) | ||
3. Imaging Protocol: Overview | 3. Imaging Protocol: Overview | ||
− | 3.1. Detail: Utilities and Endpoints of the Imaging Protocol within the Clinical Trial | + | :3.1. Detail: Utilities and Endpoints of the Imaging Protocol within the Clinical Trial |
− | 3.2. Detail: Management of Pre-enrollment Imaging Tests | + | :3.2. Detail: Management of Pre-enrollment Imaging Tests |
− | 3.3. Detail: Timing of Imaging Tests within the Clinical Trial Calendar | + | :3.3. Detail: Timing of Imaging Tests within the Clinical Trial Calendar |
− | 3.4. Detail: Management of On-protocol Imaging Performed Off-schedule | + | :3.4. Detail: Management of On-protocol Imaging Performed Off-schedule |
− | 3.5. Detail: Management of Off-protocol Imaging | + | :3.5. Detail: Management of Off-protocol Imaging |
− | 3.6. Detail: Subject Selection Criteria Related to Imaging (mainly exclusionary in nature) | + | :3.6. Detail: Subject Selection Criteria Related to Imaging (mainly exclusionary in nature) |
4. Subject Preparation | 4. Subject Preparation | ||
− | 4.1. Detail: Interval Timing (e.g., oral and/or IV intake, vigorous physical activity, timing relative to non-protocol-related medical interventions, etc.) | + | :4.1. Detail: Interval Timing (e.g., oral and/or IV intake, vigorous physical activity, timing relative to non-protocol-related medical interventions, etc.) |
− | 4.2. Detail: Specific Pre-imaging Instructions | + | :4.2. Detail: Specific Pre-imaging Instructions |
− | 4.3. Detail: Prior to Arrival | + | :4.3. Detail: Prior to Arrival |
− | 4.4. Detail: Upon Arrival (including ancillary testing associated with the imaging and downstream actions relative to such testing) | + | :4.4. Detail: Upon Arrival (including ancillary testing associated with the imaging and downstream actions relative to such testing) |
5. Imaging Procedures: General | 5. Imaging Procedures: General | ||
− | 5.1. Detail: Data that should accompany the request for a PET study | + | :5.1. Detail: Data that should accompany the request for a PET study |
− | 5.2. Detail: Imaging Agent Preparation and Specification (Contrast agent or radiopharmaceutical) | + | :5.2. Detail: Imaging Agent Preparation and Specification (Contrast agent or radiopharmaceutical) |
− | 5.3. Detail: Contrast administration: (agent, dose, route) | + | :5.3. Detail: Contrast administration: (agent, dose, route) |
− | 5.4. Detail: Procedure for performing the PET study | + | :5.4. Detail: Procedure for performing the PET study |
− | 5.5. Detail: Protocol alterations permitted in the case of multi-centre studies | + | :5.5. Detail: Protocol alterations permitted in the case of multi-centre studies |
− | 5.6. Detail: Imaging Data Acquisition | + | :5.6. Detail: Imaging Data Acquisition |
− | 5.7. Detail: Subject Positioning | + | :5.7. Detail: Subject Positioning |
− | 5.8. Detail: Instructions to Subject during Acquisition (e.g., breathing) | + | :5.8. Detail: Instructions to Subject during Acquisition (e.g., breathing) |
− | 5.9. Detail: Timing (e.g., relative to previously administered imaging agents / enhancers; inter-time point standardization) | + | :5.9. Detail: Timing (e.g., relative to previously administered imaging agents / enhancers; inter-time point standardization) |
6. Reconstruction and Reporting | 6. Reconstruction and Reporting | ||
− | 6.1. Detail: Reconstruction | + | :6.1. Detail: Reconstruction |
− | 6.2. Detail: Reporting | + | :6.2. Detail: Reporting |
− | 6.3. Detail: Interpretation and pitfalls | + | :6.3. Detail: Interpretation and pitfalls |
7. Archival Requirements for Primary Source Imaging Data | 7. Archival Requirements for Primary Source Imaging Data | ||
− | 7.1. Detail: Data should be archived in DICOM 3.0 format or the current version of DICOM recommended by XXX WG YY of the XXX. | + | :7.1. Detail: Data should be archived in DICOM 3.0 format or the current version of DICOM recommended by XXX WG YY of the XXX. |
− | 7.2. Detail: De-identification / Anonymization Schema(s) to Be Used | + | :7.2. Detail: De-identification / Anonymization Schema(s) to Be Used |
− | 7.3. Detail: Archival and Transmission of Image Data | + | :7.3. Detail: Archival and Transmission of Image Data |
− | 7.4. Detail: Transmission of Imaging Data from Sites to Central Archive | + | :7.4. Detail: Transmission of Imaging Data from Sites to Central Archive |
− | 7.5. Detail: Requirements for Local Retention of Imaging Data | + | :7.5. Detail: Requirements for Local Retention of Imaging Data |
− | 7.6. Detail: Requirements for Central Management of Imaging Data and Imaging Metadata (e.g., the results of image analysis) | + | :7.6. Detail: Requirements for Central Management of Imaging Data and Imaging Metadata (e.g., the results of image analysis) |
8. Post-processing (i.e., anything not done on an acquisition platform that affects DICOM image data and/or pixel / voxel values) | 8. Post-processing (i.e., anything not done on an acquisition platform that affects DICOM image data and/or pixel / voxel values) | ||
None prior to importation into free standing image analysis software package | None prior to importation into free standing image analysis software package | ||
9. Interpretation | 9. Interpretation | ||
− | 9.1. Detail: Image quality assessment to confirm correctness and completeness of image submission | + | :9.1. Detail: Image quality assessment to confirm correctness and completeness of image submission |
− | 9.2. Detail: Volume of interest (VOI) Definition | + | :9.2. Detail: Volume of interest (VOI) Definition |
− | 9.3. Detail: Timepoint exams defined by charter re: exam types and dates of inclusion | + | :9.3. Detail: Timepoint exams defined by charter re: exam types and dates of inclusion |
− | 9.4. Detail: @Open next timepoint for given subject | + | :9.4. Detail: @Open next timepoint for given subject |
10. Radiation Dose and Safety Considerations | 10. Radiation Dose and Safety Considerations | ||
11. Quality Control | 11. Quality Control | ||
− | 11.1. Detail: General | + | :11.1. Detail: General |
− | 11.2. Detail: Quality Control and Inter-institution Cross-Calibration | + | :11.2. Detail: Quality Control and Inter-institution Cross-Calibration |
12. Required Documentation | 12. Required Documentation | ||
− | 12.1. Detail: Subject preparation | + | :12.1. Detail: Subject preparation |
− | 12.2. Detail: Imaging agent dose calculation | + | :12.2. Detail: Imaging agent dose calculation |
− | 12.3. Detail: Imaging agent-related | + | :12.3. Detail: Imaging agent-related |
− | 12.4. Detail: Image data acquisition-related | + | :12.4. Detail: Image data acquisition-related |
− | 12.5. Detail: Inherent image data reconstruction / processing | + | :12.5. Detail: Inherent image data reconstruction / processing |
− | 12.6. Detail: Image analysis and interpretation | + | :12.6. Detail: Image analysis and interpretation |
− | 12.7. Detail: Site selection and Quality Control | + | :12.7. Detail: Site selection and Quality Control |
13. Acknowledgements | 13. Acknowledgements |
Revision as of 18:20, 29 June 2009
FDG-PET/CT draft template GSD, June 29, 2009
FYI: The complete draft of the QIBA FDG-PET/CT Whole Body protocol is posted at http://qibawiki.rsna.org/index.php?title=Profile:_FDG-PET_Whole_Body
1. Executive Summary, Introduction and Background Information
- 1.1. Principle
- 1.2. Indications
- 1.3. Relationship with other diagnostic methods
- 1.4. Covariates (note – please see full FDG-PET document; should this material be in other sections of the document?)
2. Claims (what users will be able to achieve)
- 2.1 Claim #1:
- 2.2. Claim #2:
- 2.3. Claim #3:
- 2.4. Claim #4:
- 2.5. Claim #5: (etc.)
3. Imaging Protocol: Overview
- 3.1. Detail: Utilities and Endpoints of the Imaging Protocol within the Clinical Trial
- 3.2. Detail: Management of Pre-enrollment Imaging Tests
- 3.3. Detail: Timing of Imaging Tests within the Clinical Trial Calendar
- 3.4. Detail: Management of On-protocol Imaging Performed Off-schedule
- 3.5. Detail: Management of Off-protocol Imaging
- 3.6. Detail: Subject Selection Criteria Related to Imaging (mainly exclusionary in nature)
4. Subject Preparation
- 4.1. Detail: Interval Timing (e.g., oral and/or IV intake, vigorous physical activity, timing relative to non-protocol-related medical interventions, etc.)
- 4.2. Detail: Specific Pre-imaging Instructions
- 4.3. Detail: Prior to Arrival
- 4.4. Detail: Upon Arrival (including ancillary testing associated with the imaging and downstream actions relative to such testing)
5. Imaging Procedures: General
- 5.1. Detail: Data that should accompany the request for a PET study
- 5.2. Detail: Imaging Agent Preparation and Specification (Contrast agent or radiopharmaceutical)
- 5.3. Detail: Contrast administration: (agent, dose, route)
- 5.4. Detail: Procedure for performing the PET study
- 5.5. Detail: Protocol alterations permitted in the case of multi-centre studies
- 5.6. Detail: Imaging Data Acquisition
- 5.7. Detail: Subject Positioning
- 5.8. Detail: Instructions to Subject during Acquisition (e.g., breathing)
- 5.9. Detail: Timing (e.g., relative to previously administered imaging agents / enhancers; inter-time point standardization)
6. Reconstruction and Reporting
- 6.1. Detail: Reconstruction
- 6.2. Detail: Reporting
- 6.3. Detail: Interpretation and pitfalls
7. Archival Requirements for Primary Source Imaging Data
- 7.1. Detail: Data should be archived in DICOM 3.0 format or the current version of DICOM recommended by XXX WG YY of the XXX.
- 7.2. Detail: De-identification / Anonymization Schema(s) to Be Used
- 7.3. Detail: Archival and Transmission of Image Data
- 7.4. Detail: Transmission of Imaging Data from Sites to Central Archive
- 7.5. Detail: Requirements for Local Retention of Imaging Data
- 7.6. Detail: Requirements for Central Management of Imaging Data and Imaging Metadata (e.g., the results of image analysis)
8. Post-processing (i.e., anything not done on an acquisition platform that affects DICOM image data and/or pixel / voxel values) None prior to importation into free standing image analysis software package 9. Interpretation
- 9.1. Detail: Image quality assessment to confirm correctness and completeness of image submission
- 9.2. Detail: Volume of interest (VOI) Definition
- 9.3. Detail: Timepoint exams defined by charter re: exam types and dates of inclusion
- 9.4. Detail: @Open next timepoint for given subject
10. Radiation Dose and Safety Considerations 11. Quality Control
- 11.1. Detail: General
- 11.2. Detail: Quality Control and Inter-institution Cross-Calibration
12. Required Documentation
- 12.1. Detail: Subject preparation
- 12.2. Detail: Imaging agent dose calculation
- 12.3. Detail: Imaging agent-related
- 12.4. Detail: Image data acquisition-related
- 12.5. Detail: Inherent image data reconstruction / processing
- 12.6. Detail: Image analysis and interpretation
- 12.7. Detail: Site selection and Quality Control
13. Acknowledgements